<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="342988">
  <stage>Registered</stage>
  <submitdate>23/06/2011</submitdate>
  <approvaldate>7/07/2011</approvaldate>
  <actrnumber>ACTRN12611000692932</actrnumber>
  <trial_identification>
    <studytitle>Dietary fat, airway inflammation and bronchodilator response in asthma - Study 1</studytitle>
    <scientifictitle>A randomised controlled, 3-way crossover trial, to examine the effects of a high fat or carbohydrate meal on bronchodilation in adults with stable asthma.</scientifictitle>
    <utrn />
    <trialacronym>FAB Study - Study 1</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Asthma</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Asthma</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>At each visit, participants will consume a study meal. The order in which the study meals will be consumed will be randomly allocated. There will be a washout period of 1 week between visits. The study meals are as follows:
1. Fat: 100mL double cream, providing 45g (96%) fat, 29g saturated fat, 1740kJ.
2. Carbohydrate: 104g high energy drink, providing 100% carbohydrate, 1740kJ.
3. Control: 100mL water
Participants will be asked to consume each meal within a 15 minute timeframe.
On arrival baseline lung function will be performed followed by the administration of a short acting B2-agonist (salbutamol 400ug, inhaled via a spacer). The participant will then consume the study meal. 
Participants who complete Study 1 may also participate in Study 2.</interventions>
    <comparator>The comparator or control intervention will be 100mL water.</comparator>
    <control>Placebo</control>
    <interventioncode>Prevention</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Lung function (FEV1, FVC) assessed using spirometry.</outcome>
      <timepoint>Study 1: Baseline, then repeated hourly for the next 6 hours.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Respiratory impedance using impulse oscillometry.</outcome>
      <timepoint>Study 1: Baseline, then repeated hourly for the next 6 hours.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Stable asthma, non smokers</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>BMI &gt; 35, history of coronary heart disease, diabetes or currently taking lipid lowering drugs or oral corticosteroids.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Prevention</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>After screening for eligibility, participants will be assigned to the next available study number. Allocation will be concealed by blinded list held by an independent statistician.</concealment>
    <sequence>Computer generated sequence, using a randomisation table created by computer software.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures>This project consists of 2 studies.
Study 1: Effects of macronutrients on bronchodilation (described here)
Study 2: Effects of macronutrients on bronchoprotection (please see study 2 entry)
Participants may consent to participate in 1 or both studies associated with this project.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>4/07/2011</anticipatedstartdate>
    <actualstartdate>2/11/2012</actualstartdate>
    <anticipatedenddate />
    <actualenddate>28/07/2014</actualenddate>
    <samplesize>21</samplesize>
    <actualsamplesize>15</actualsamplesize>
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>John Hunter Hospital</primarysponsorname>
    <primarysponsoraddress>Lookout Road
New Lambton Heights NSW 2305</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>Dr Lisa Wood</fundingname>
      <fundingaddress>Respiratory and Sleep Medicine
HMRI Level 3
John Hunter Hospital
Lookout Road
New Lambton Heights NSW 2305</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Newcastle</sponsorname>
      <sponsoraddress>University Drive
Callaghan NSW 2308</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aim of this project is to examine whether impaired bronchodilator recovery in asthma is due to: 1. reduced bronchodilation and/or 2. reduced bronchoprotection. This will be explored in 2 studies. Participants can participate in 1 or both of these studies. Study 1 is described below.
Study 1. Effects of macronutrients on bronchodilation
At baseline, participants will consume the study meal (fat, carbohydrate or water), then their lung function will be assessed. They then will be administered with a short acting B2-agonist (salbutamol 400ug). Lung function measurements will then be repeated hourly, for the next 6 hours.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Hunter New England Human Research Ethics Committee</ethicname>
      <ethicaddress>Lookout Road
New Lambton Heights NSW 2305</ethicaddress>
      <ethicapprovaldate>23/06/2011</ethicapprovaldate>
      <hrec>11/06/15/4.02</hrec>
      <ethicsubmitdate>31/05/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Lisa Wood</name>
      <address>Centre for Asthma and Respiratory Diseases
Level 2, West Wing, HMRI Building
Kookaburra Crt
New Lambton Heights, NSW, 2305
AUSTRALIA
</address>
      <phone>+61 2 4042 0147</phone>
      <fax>+61 2 4042 0046</fax>
      <email>lisa.wood@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Lisa Wood</name>
      <address>Centre for Asthma and Respiratory Diseases
Level 2, West Wing, HMRI Building
Kookaburra Crt
New Lambton Heights, NSW, 2305
AUSTRALIA
</address>
      <phone>+61240420147</phone>
      <fax>+61 2 40420046</fax>
      <email>lisa.wood@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Bronwyn Berthon</name>
      <address>Centre for Asthma and Respiratory Diseases
Level 2, West Wing, HMRI Building
Kookaburra Crt
New Lambton Heights, NSW, 2305
AUSTRALIA
</address>
      <phone>+ 61 2 40420116</phone>
      <fax>+61 2 4042 0046</fax>
      <email>bronwyn.berthon@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Lisa Wood</name>
      <address>Centre for Asthma and Respiratory Diseases
Level 2, West Wing, HMRI Building
Kookaburra Crt
New Lambton Heights, NSW, 2305
AUSTRALIA
</address>
      <phone>+61240420147</phone>
      <fax>+61 2 4042 0046</fax>
      <email>lisa.wood@newcastle.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>